• Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
HBOT News Network Logo
  • Home
  • Special Reports
  • News & Research
  • Conversations
  • Research Rundowns
  • International Indications
Veterans Special Report
  • Home
  • Special Reports
  • News & Research
  • Conversations
  • Research Rundowns
  • International Indications

Successful treatment of rhino-orbital mucormycosis with posaconazole and hyperbaric oxygen therapy.

by HBOT News | Mar 1, 2013 | Leukemia

Abstract: Mucormycosis is a rare, but invasive infection caused by ubiquitous molds. Amphotericin B and surgery have been known to help improve the outcome. Sporadic case reports support the use of posaconazole in adults. We report a toddler with acute lymphoblastic...

Recent Posts

  • A New Cancer Protocol Using Ivermectin and HBOT? Exploring the MSCC Theory
  • Healing Hidden Wounds: Kentucky Veterans Find Hope in Hyperbaric Oxygen Therapy
  • Invisible Wounds of War: Ryan Larkin’s Story and the Role of HBOT in Healing Brain Injuries
  • HBOT Saves Girl’s Nose: The Science Explained
  • HBOT Shows Promise in Treating Femoral-Head Avascular Necrosis

Archives

Categories

Hyperbaric Oxygen Therapy is used around the world to extend and improve quality of life by augmenting the treatment of all injuries, diseases and infections, as well as to improve overall wellness. HBOT involves breathing 100% oxygen in a pressurized chamber to increase oxygen levels in blood plasma. A century of clinical research has shown that increased oxygen in plasma accelerates our natural ability to heal through neurogenesis and angiogenesis.
  • Follow
  • Follow
  • Follow
  • Follow
  • Policies
  • Contact

Our Newsletter

Join our mailing list and get notified when we publish news or record new episodes.

Name(Required)

© 2015-2023 HBOT News – Your news source for the latest news and research about hyperbaric oxygen therapy.